Table 2. Chronic medications and outcomes.
|
Variables |
I NYHA( n=32) |
II NYHA(n=78) |
III NYHA(n=62) |
IV NYHA (n=31) |
P value |
|
Diuretics (n) |
9(28%) |
29(37%) |
31(50%) |
11(35%) |
0.28 |
|
Beta-blockers (n) |
18(56%) |
48(62%) |
35(56%) |
12(38%) |
0.21 |
|
ACE-inhibitors (n) |
17(53%) |
43(55%) |
34(55%) |
16(51%) |
0.97 |
|
Nitrates (n) |
3(9%) |
3(4%) |
6(10%) |
3(10%) |
0.53 |
|
Digoxin (n) |
1(3%) |
5(6%) |
7(11%) |
6(19%) |
0.12 |
|
Statines (n) |
3(9%) |
3(4%) |
4(6%) |
1(3%) |
0.91 |
|
Heparine (n ) |
0 |
0 |
0 |
1(3%) |
0.20 |
|
Calcium channel blockers (n) |
0 |
1(1%) |
1(2%) |
3(10%) |
0.05 |
|
Thrombosis (n) |
0 |
0 |
1(2%) |
4(13%) |
0.39 |
Note. The comparisons were made using the chi-square test.